文献速递重症综合管理与镇静镇痛

重症监护环境中整群随机试验的伦理与方法学特征:系统综述

Ethical and Methodological Features of Cluster Randomized Trials in Critical Care Settings: A Systematic Review.
PubMed 文献 · Crit Care Med · 2026-09-07
一句话结论系统综述纳入2004至2022年102项重症CRT,发现注册、伦理审查、知情同意及样本量计算等伦理与方法学报告仍存在缺陷,作者认为需加强报告标准并遵循《渥太华声明》。

该系统综述检索MEDLINE和Embase,纳入2004至2022年发表的102项重症监护整群随机试验(CRT)原始报告,由两名评价者独立提取伦理与方法学特征。结果显示:77项(78%)报告试验注册,101项(99%)报告研究伦理委员会审查,5项(5%)获豁免审查;常见设计为平行组48项(47%)、两周期交叉23项(23%)、阶梯楔形20项(20%)、多周期交叉8项(8%)。47项(46%)提供了采用整群随机的理由;99项(97%)将患者和照护者确定为研究参与者,其中74项(75%)报告知情同意情况,最常见为豁免同意(36项,49%);48项(47%)将医护人员确定为研究参与者,其中11项(23%)报告知情同意情况。82项(80%)报告样本量或把握度计算,其中67项(82%)考虑了群内相关系数;77项(76%)在主分析中考虑群内相关系数;85项群数少于40的试验中,11项(13%)报告了小样本校正。作者认为重症CRT的伦理与方法学缺陷持续存在,需加强报告标准并遵循包括《渥太华声明》在内的既定伦理框架。

要点

  • 102项重症CRT中,101项(99%)报告研究伦理委员会审查,5项(5%)获豁免审查;77项(78%)报告试验注册。
  • 99项(97%)将患者和照护者确定为研究参与者,其中74项(75%)报告知情同意情况,最常见为豁免同意(36项,49%)。
  • 48项(47%)将医护人员确定为研究参与者,其中仅11项(23%)报告知情同意情况。
  • 82项(80%)报告样本量或把握度计算,其中67项(82%)考虑了群内相关系数;77项(76%)在主分析中考虑群内相关系数。
  • 85项群数少于40的试验中,仅11项(13%)报告了小样本校正。

适用人群与场景

  • 2004至2022年以英文发表的、在重症监护环境中开展的整群随机试验(CRT)原始报告。

研究设计与关键结果

  • 研究类型:系统综述;检索MEDLINE和Embase;纳入2004至2022年英文发表的102项重症监护整群随机试验原始报告。
  • 102项CRT中,77项(78%)报告试验注册,101项(99%)报告研究伦理委员会审查,5项(5%)获豁免审查。
  • 常见设计:平行组48项(47%)、两周期交叉23项(23%)、阶梯楔形20项(20%)、多周期交叉8项(8%);47项(46%)提供了采用整群随机的理由。
  • 患者和照护者被确定为研究参与者的99项(97%)中,74项(75%)报告知情同意情况,最常见为豁免同意(36项,49%)。
  • 医护人员被确定为研究参与者的48项(47%)中,11项(23%)报告知情同意情况。
  • 82项(80%)报告样本量或把握度计算,其中67项(82%)考虑了群内相关系数;77项(76%)在主分析中考虑群内相关系数。
  • 85项群数少于40的CRT中,11项(13%)报告了小样本校正。

证据类型、等级与局限

  • 证据类型:系统综述。
  • 作者结论:重症CRT的伦理与方法学缺陷持续存在;需加强报告标准并遵循包括《渥太华声明》在内的既定伦理框架,以确保重症研究这一重要设计具有科学和伦理完整性。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,需加强报告标准并遵循包括《渥太华声明》在内的既定伦理框架,以确保重症监护整群随机试验的科学与伦理完整性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Cluster randomized trials (CRTs) are useful for evaluating system-level interventions in critical care but raise complex ethical and methodological issues that are amplified in this setting. We aimed to describe ethical and methodological features of CRTs in critical care settings.

DATA SOURCES: We performed a systematic literature search in MEDLINE and Embase.

STUDY SELECTION: We included primary reports of CRTs in critical care settings published from 2004 to 2022 in English.

DATA EXTRACTION: Two reviewers independently extracted data from each CRT, resolving any discrepancies by consensus.

DATA SYNTHESIS: Among 102 CRTs, 77 CRTs (78%) reported trial registration and 101 CRTs (99%) reported research ethics committee review; five CRTs (5%) were exempted from review. Common designs were parallel-arm (48, 47%), two-period crossover (23, 23%), stepped-wedge (20, 20%), and multi-period crossover (8, 8%). A justification for using cluster randomization was provided in 47 CRTs (46%). Patients and caregivers were identified as research participants in 99 CRTs (97%). Of these, 74 CRTs (75%) reported on consent, which was most commonly waived consent (36, 49%). Healthcare providers were identified as research participants in 48 CRTs (47%). Of these, 11 CRTs (23%) reported on consent. Most (82, 80%) reported a sample size or power calculation, with 67 CRTs (82%) accounting for the intracluster correlation; 77 CRTs (76%) accounted for the intracluster correlation in the primary analysis. Among 85 CRTs with fewer than 40 clusters, 11 CRTs (13%) reported a small sample correction.

CONCLUSIONS: Ethical and methodological shortcomings persist in CRTs. Enhanced reporting standards and adherence to established ethical frameworks, including the Ottawa Statement, are needed to ensure both scientific and ethical integrity in this essential design in critical care research.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Walser E, Goldstein CE, Shaw JF, et al. Ethical and Methodological Features of Cluster Randomized Trials in Critical Care Settings: A Systematic Review. Crit Care Med. 2026. PMID: 42704256. doi:10.1097/CCM.0000000000007340

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。